FundedIQ
Biotechnology

Scohia Pharma

Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.

www.scohia.com Fujisawa, Japan 11-50 employees
Total raised
$443M
Rounds
1
Latest
Series Unknown
May 2026

Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.

Scohia Pharma has raised $443M across 1 round. Its most recent round was a Series Unknown of $443M in May 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with FundedIQ

1 round on record.

Date
Round
Amount
Lead investor
May 28, 2026
Series Unknown
$443M

Unlock the lead investor and full details for this round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Scohia Pharma is featured in

Similar companies

Arrowsmith

Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance.

Series A $6.5M
Sonire Therapeutics

SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel therapeutic modality with the goal of giving cancer patients and their families a new future.

Series Unknown $13.0M
LIFESCAPES

LIFESCAPES is a researcher and manufacturer of brain-computer interface equipment. LIFESCAPES aims to use BMI technology to help stroke patients solve problems and improve their quality of life. LIFESCAPES uses BMI to bring out the plasticity of the brain and help people who are in trouble to be free of their limitations and to live their lives normally.

Series Unknown $3.7M
Dioseve

Dioseve is providing novel possibilities for all life.

Series A $6.2M
GoldenHarvest

The GoldenHarvest vision is an ecosystem focused on the life operation that represents a new relationship between people and non-human species.

Series Unknown $120k
Gel-Coat Biomaterials

Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.

Series A $1.3M
Molmir

Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.

Series A $1.9M
Restore Vision

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa. Restore Vision develops eye disease therapeutic agents.

Series B $8.2M
Think Nature

Think Nature is a researcher startup that specializes in the solutions related to the sustainability of biodiversity and ecosystem services.

Series Unknown $2.4M
Metagen Therapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Series B $15.7M
Pixelgen Technologies

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and diagnostics through the development of innovative technologies.

Series B $15.5M
Novir

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart.

Seed $3.1M
14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.